biospecimen__admin__batch_number	345.53.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	604CD652-C4AF-43D9-9B4A-C3E21C80BDC2
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-ED-A7PY-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-ED-A7PY-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-ED-A7PY-01A
biospecimen__bio__biospecimen_barcode_bottom	0160357068
biospecimen__bio__day_of_creation	24
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	09
biospecimen__bio__month_of_shipment	10
biospecimen__bio__pathology_report_file_name	TCGA-ED-A7PY.B6D3F89E-C1A5-445A-B9BD-047B2FB92E4C.pdf
biospecimen__bio__plate_column	5
biospecimen__bio__plate_id	A343
biospecimen__bio__plate_row	A
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-ED-A7PY
biospecimen__shared__patient_id	A7PY
clinical__ablation__ablation_performed_indicator	YES
clinical__ablation__ablation_type	Ethanol Injection
clinical__ablation__bcr_ablation_barcode	TCGA-ED-A7PY-A64278
clinical__ablation__bcr_ablation_uuid	867D2F96-7949-4978-8BF0-0176298728EF
clinical__ablation__days_to_ablation_performed	82
clinical__ablation__embolization_performed_indicator	NO
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	53E478B5-85B3-4BDA-A965-A6388F3722FA
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__creatinine_lower_level	4.0
clinical__chol_lihc_shared__creatinine_upper_limit	5.8
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	3.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	20
clinical__chol_lihc_shared__fetoprotein_outcome_value	2
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.3
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	20
clinical__clin_shared__bcr_followup_barcode	TCGA-ED-A7PY-F62651
clinical__clin_shared__bcr_followup_uuid	179AF171-BB74-4E36-94BD-CF78404AEBE3
clinical__clin_shared__day_of_form_completion	7
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	1
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	282
clinical__clin_shared__post_op_ablation_embolization_tx	YES
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	a20c3e79-d349-4df2-a27a-8e94cce34fea
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-ED-A7PY-01A-11R-A343-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	da85e4b3-53a9-413d-9c92-67c8bc177ee7
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	6d77082c-c6d5-47ee-8c48-c153b91bfb81
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	a396e048-5aa0-4d71-96bd-7f4fdf6934aa
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:34:57.516354-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	3cf0ae94-08db-51b5-aae3-571da3e649cb
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1993
gdc__diagnoses__age_at_diagnosis	7556
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-7556.0
gdc__diagnoses__days_to_last_follow_up	390.0
gdc__diagnoses__diagnosis_id	27aee0ed-c36f-5f21-8aca-df1e47271b46
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	16.43655489809336
gdc__exposures__exposure_id	546a8538-1f7b-5e76-9303-7c60d48ac99e
gdc__exposures__height	156.0
gdc__exposures__weight	40.0
gdc__file_id	8002d093-ede5-47e8-85aa-74918b5aed2b
gdc__file_name	4c27833c-e999-46e9-bd70-d24774c2498a.mirbase21.mirnas.quantification.txt
gdc__file_size	50261
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	538ab55d1c7950659cf665ee0686c529
gdc__portions__is_ffpe	false
gdc__portions__portion_id	36642ce2-edd1-4c44-ac76-a99ed9ee22ed
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	83
gdc__samples__initial_weight	1380.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	B6D3F89E-C1A5-445A-B9BD-047B2FB92E4C
gdc__samples__sample_id	7c611dd6-6237-45f6-ae24-50bfa63d7835
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	4b42971a-a109-4c19-aa70-ac2db0ba2936
gdc__submitter_id	mirna_swap_dr11_208_MirnaExpression76688062-f41a-48ad-b992-04c726a56aa6_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	ED
gdc__tissue_source_site__name	Asterand
gdc__tissue_source_site__tissue_source_site_id	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4
gdc__treatments__treatment_id	22fd35dd-f118-5484-b055-08dd736a1618
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:10:15.882+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a20c3e79-d349-4df2-a27a-8e94cce34fea-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a20c3e79-d349-4df2-a27a-8e94cce34fea-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129632
manually_curated__local_md5	60b3ddb6cd45d1d59cd503cd76e344b7
manually_curated__opengdc_download_date	2018-10-16T17:09:59.000049+02:00
manually_curated__opengdc_file_md5	f8ce27025636a256ec2750cd88820b10
manually_curated__opengdc_file_size	50260
manually_curated__opengdc_id	a20c3e79-d349-4df2-a27a-8e94cce34fea-meq
manually_curated__origin_file_size	129632
manually_curated__origin_last_modified_date	Tue Oct 16 17:37:00 CEST 2018
manually_curated__origin_md5	60b3ddb6cd45d1d59cd503cd76e344b7
manually_curated__tissue_status	tumoral
